AI Image
Startup Deploys AI-Engineered Virus on Human Patient
Futurism • • health
Key Points:
- Radical Numerics, a startup, claims to have successfully treated a bacterial infection using an AI-engineered viral therapy, a process known as phage therapy that targets harmful bacteria with specific viruses.
- The company published a technical paper on its website detailing the trial, but the study has not been peer-reviewed or published in a scientific journal, raising questions about its credibility.
- Radical Numerics declined to share clinical details or information about the patient and doctors involved, citing proprietary concerns and patient confidentiality.
- Experts, including Harvard microbiologist Michael Baym, express skepticism about the claims, emphasizing the need for rigorous scientific validation.
- The situation highlights the challenges and ethical considerations of using AI-generated viruses in medical treatments, especially when commercial interests are involved.
